drugset / Trial / NCT00003103

Chemotherapy in Treating Patients With Solid Tumors

NCT00003103

Phase 1/2 Completed 57 enrolled Memorial Sloan Kettering Cancer Center
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of oblimersen in treating patients who have solid tumors that have not responded to previous therapy.

Timeline

Start
1997-08
Primary completion
2002-08
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule Intravenous
Subject oblimersen sodium Antisense oligonucleotide Intravenous